FDA Issues Nationwide Recall of Telmisartan and Amlodipine Bottles
The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine due to dosage potency issues.
The U.S. Food and Drug Administration announced a voluntary recall of telmisartan and amlodipine tablets distributed in 30-count bottles by Mylan Pharmaceuticals. The recall covers 40-mg telmisartan and 5-mg amlodipine doses with lot numbers 3228113, 3228114, 3228115 (expiring Oct. 31, 2026) and 3228120, 3228121 (expiring Nov. 30, 2026).
The FDA classified the recall as Class III, indicating that consumption of the affected medication is not expected to cause adverse health effects. Patients prescribed these drugs are advised to verify their bottle’s lot number, discontinue use if it matches the recalled batches, and consult a healthcare professional. Returned medication may be eligible for a refund at the pharmacy.
For further information, the FDA can be reached at 1-888-463-6332.